TPG Group Holdings (SBS) Advisors, Inc.

TPG Group Holdings (SBS) Advisors, Inc. discloses dealings in 22 companies, chiefly Progyny, Inc., Allogene Therapeutics, Inc. and TPG RE Finance Trust, Inc. In total, 264 filings cover trades dated from 5 January 2016 to 12 October 2021.

Market trades split into 24 purchases (€55.9M) and 204 sales (€4.3B). Sales outweigh purchases by €4.2B. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants.

The median purchase comes to €696k. 10 out of 22 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of +7.1%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 25 February 2022, the filings show a transaction worth €33k in TPG RE Finance Trust, Inc. The last insider purchase was made public on 23 September 2020, 2,221 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.